SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
BCLI - BrainStorm Cell Therapeutics Inc.
An SI Board Since August 2005
Posts SubjectMarks Bans Symbol
288 7 0 BCLI
Emcee:  whenitgoesup Type:  Moderated
Introduction Market Data Compact
BrainStorm Cell Therapeutics Inc. (OTCBB BCLI): develops NurOwn cell therapy products sourced from adult stem cells for treatment of neurodegenerative diseases. It primarily focuses on the utilization of patients’ own bone marrow stem cells to generate neuron-like cells that would provide a treatment for Parkinson's disease, as well as for multiple sclerosis and other neurodegenerative disorders. The company was incorporated in 2000 under the name Wizbang Technologies, Inc. and changed its name to Golden Hand Resources, Inc. in 2003. Further, the name was changed to Brainstorm Cell Therapeutics, Inc. in 2004. Brainstorm Cell Therapeutics is based in New York City.
Website: brainstorm-cell.com
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
288Watching this one - Closed @ .419 But the general market need to finish the coCrazyTrain-8/7/2011
287BrainStorm Appoints Dr. Adrian Harel as Chief Operating Officer and Acting Chiefxcentral111/24/2011
286+27% today to 0.60Topannuity-7/3/2007
285running!! any known reasons?Topannuity-2/23/2007
284BCLI .49 x .52 - stem cell play - Parkinsons, ALS and other neurological diseaserrufff-5/31/2006
283Cell to buy? Brainstorm Cell Therapeutics is one of the interesting but highly midastouch017-3/29/2006
282BrainStorm Shareholders Extend Lock-Up Agreement Last Update: 10:00 AM ET Mar 2midastouch017-3/29/2006
281WallStreet Research Initiates Coverage of BrainStorm Cell Therapeutics' Sharmidastouch017-3/27/2006
280<b><i>BrainStorm Cell Therapeutics, CFO Dudy Stolick Interview by Erjmhollen-3/13/2006
279BrainStorm's Stem Cell Hospital Partnering Gets Media Coverage Monday Februmidastouch017-2/27/2006
278Shazamstocks.com Announces Profile Launch of BrainStorm Cell Therapeutics Mondamidastouch017-2/27/2006
277Volume will do it - when there's interest the MM's can't play the usrrufff-2/1/2006
276Hmmmm........have to close that 10 cent gap..What do you think? .54 .55 or maybeBenny-Rubin-2/1/2006
275Holding that .60 on moderate volume. Wouldn't take much to get it back to trrufff-1/31/2006
274.5521? Wow! 21 is my lucky number!whenitgoesup-1/31/2006
273check out that funny looking odd bid, I wonder who did that? :)Benny-Rubin-1/31/2006
272Dubi, I was on the horn with them early this morning.Send me a PM good stuff.Benny-Rubin-1/31/2006
271Unfortunately, Rrufff, not all companies respond. We have one of them in common midastouch017-1/31/2006
270Dubi, Thanks for your efforts. Always nice to have a poster who is pro-active rrufff-1/31/2006
269Yep, this indeed was it. This is the last message received, From: dubi Sent: Tmidastouch017-1/31/2006
268Do you think that was the PR the guy promised you for January?whenitgoesup-1/30/2006
267Strong again today .65 +.07whenitgoesup-1/30/2006
266Give it about 4 weeks should be interesting.Benny-Rubin-1/27/2006
265This is looking very strong, chart is awesome.rrufff-1/27/2006
264Robust volume, correct direction :) Dubimidastouch017-1/27/2006
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News